{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:09:01Z","timestamp":1788930541944,"version":"build-2803163510"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Inverse psoriasis is a relatively rare and distinct subtype of psoriasis whose pathogenesis remains incompletely understood. The particular location of lesions presents significant therapeutic challenges, and no consensus guidelines are currently available. Immune mediated inflammation plays a key role in disease development. Lesions are susceptible to riction and moisture, which reduces treatment tolerance in affected areas. We report a case of a 32-year-old male patient with inverse psoriasis successfully treated with ustekinumab. The patient received four subcutaneous injections of ustekinumab, and after 24 weeks of treatment, both skin lesions and pruritus showed marked improvement. Our experience suggests that ustekinumab may represent a novel therapeutic approach for this psoriasis subtype.<\/jats:p>","DOI":"10.3389\/fmed.2026.1939968","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:44:08Z","timestamp":1788929048000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment of inverse psoriasis with ustekinumab: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Yongjun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huangshi Central Hospital Graduate Joint Training Base, School of Medicine, Wuhan University of Science and Technology","place":["Huangshi, China"]},{"name":"The First Clinical School, Hubei Polytechnic University","place":["Huangshi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huangshi Central Hospital Graduate Joint Training Base, School of Medicine, Wuhan University of Science and Technology","place":["Huangshi, China"]},{"name":"School of Medicine, Wuhan University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huangshi Central Hospital Graduate Joint Training Base, School of Medicine, Wuhan University of Science and Technology","place":["Huangshi, China"]},{"name":"School of Medicine, Wuhan University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huangshi Central Hospital Graduate Joint Training Base, School of Medicine, Wuhan University of Science and Technology","place":["Huangshi, China"]},{"name":"The First Clinical School, Hubei Polytechnic University","place":["Huangshi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"122991","DOI":"10.1016\/j.lfs.2024.122991","article-title":"Advances in psoriasis research: from pathogenesis to therapeutics","volume":"355","author":"Sugumaran","year":"2024","journal-title":"Life Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/cup.14142","article-title":"Histopathologic features of inverse psoriasis","volume":"49","author":"Knabel","year":"2022","journal-title":"J Cutan Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.2147\/JMDH.S536740","article-title":"The inverse association of psoriasis and Life's Crucial 9 in US adults: an analysis from NHANES","volume":"18","author":"Hao","year":"2025","journal-title":"J Multidiscip Healthc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/S40291-025-00776-8","article-title":"Psoriasis: a multidimensional review of onset, progression, treatment, and the evolution of disease models","volume":"29","author":"Pan","year":"2025","journal-title":"Mol Diagn Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s13555-025-01393-3","article-title":"Management of challenging psoriasis clinical scenarios","volume":"15","author":"Stein Gold","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.det.2024.02.001","article-title":"Biologics for psoriasis","volume":"42","author":"Wride","year":"2024","journal-title":"Dermatol Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/PTT.S509495","article-title":"Updates on psoriasis in special areas","volume":"13","author":"Butacu","year":"2024","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamadermatol.2023.5129","article-title":"Erythrasma","volume":"160","author":"Pan","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0024225","DOI":"10.1128\/cmr.00242-25","article-title":"Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi","volume":"39","author":"Steinbrink","year":"2026","journal-title":"Clin Microbiol Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/jdv.20052","article-title":"Differential diagnosis of contact dermatitis: a practical-approach review by the EADV task force on contact dermatitis","volume":"38","author":"Pesqu\u00e9","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"115429","DOI":"10.1016\/j.intimp.2025.115429","article-title":"Advancing insights into psoriasis: from pathogenesis to current and emerging therapies","volume":"165","author":"Gon\u00e7alves","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/ijd.17252","article-title":"Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents","volume":"63","author":"Mastorino","year":"2024","journal-title":"Int J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1111\/jdv.20346","article-title":"Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: a 52-week multicenter study","volume":"39","author":"Ceravalls","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1789385","DOI":"10.3389\/fmed.2026.1789385","article-title":"Guselkumab is effective in the treatment of inverse psoriasis: a case report and literature review","volume":"13","author":"Wu","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B15","first-page":"71","article-title":"Treatment of psoriasis with II-17 inhibitors: comparison of long-term effectiveness and drug survival of secukinumab vs. ixekizumab in real-world practice","volume":"15","author":"Lam","year":"2025","journal-title":"Psoriasis (Auckl)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2241941","DOI":"10.1080\/09546634.2023.2241941","article-title":"Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience","volume":"34","author":"G\u00f6n\u00fclal","year":"2023","journal-title":"J Dermatolog Treat"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1939968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:44:11Z","timestamp":1788929051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1939968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":16,"alternative-id":["10.3389\/fmed.2026.1939968"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1939968","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1939968"}}